The construction of a BSL-3 facility suitable for manufacturing the drug substance of Covaxin is underway. The vaccine maker intends to produce 5 million to 15 million doses of Covaxin drug substance.

Source

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x